Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...
In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price ...
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...
4h
Lebanon Daily News on MSNLebanon County to receive another round of opioid settlement funds. How it will be used.Lebanon County is expected to receive $3.6 million from a second wave of opioid settlement funds, which officials will use create new programs.
Johnson & Johnson (NYSE:JNJ) is reportedly suing Samsung Bioepis for breach of contract related to the launch of a biosimilar ...
Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results